| ★ | Is Continuous Ketone Monitoring Future of Diabetes Care? | | 270 | Estados Unidos | |
| 10 | How I Track Ketosis for my Mental Health | Lauren Kennedy West @livingwellafterschizophrenia | 26.7K | Canadá | 88 |
| 14 | Diabetic Ketoacidosis | Pathophysiology | Causes | Symptoms | Diagnose | Management | RajNEET Medical Education @rajneetmedicaleducation | 13.8K | India | 88 |
| 13 | A real case of Diabetic Ketoacidosis (DKA) & Management | Tiny Medicine @tinymedicine | 7.1K | Estados Unidos | 88 |
| 17 | Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS | | 4.3K | Estados Unidos | 87 |
| 18 | Diabetes Dialogue: The ADA’s Statement on Diabetes Tech Integration, With Eugene Wright Jr., MD | | 584 | Estados Unidos | 87 |
| 7 | Diabetes Technology at a Turning Point: What’s New and What’s Next | | 581 | Estados Unidos | 89 |
| 1 | Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes | | 475 | Estados Unidos | 95 |
| 8 | Diabetes Dialogue: Glucose-Ketone Monitoring, Dexcom Sensor Crime Spree, & More | | 342 | Estados Unidos | 88 |
| 4 | The World’s First Dual Glucose-Ketone Monitor Receives Clearance in Europe | | 313 | Estados Unidos | 91 |
| 6 | Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026 | | 224 | Estados Unidos | 89 |
| 11 | Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD | | 196 | Estados Unidos | 88 |
| 3 | Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 92 |
| 9 | Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS | | 94 | Estados Unidos | 88 |
| 15 | Unlock Your Health: Understanding Blood Sugar with Continuous Glucose Monitors (CGMs) | | 93 | — | 88 |
| 12 | Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 88 |
| 16 | Diabetes Type 1 - Understanding screening for long-term complications | AboutKidsHealth at SickKids | AboutKidsHealth - The Hospital for Sick Children @aboutkidshealth | 67 | Canadá | 88 |
| 5 | How Continuous Glucose Monitoring Will Evolve for #type2diabetes | | 59 | Estados Unidos | 89 |
| 20 | Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients | | 53 | Estados Unidos | 87 |
| 19 | Is Your Child at Risk for for Type 1 Diabetes? Early Screening Makes a Difference | DarioHealth @dariohealthwellbeing | 52 | Estados Unidos | 87 |
| 2 | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 92 |